Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind comparison of goat-horn-substituted Qingfei Xiaoyan Wan versus original antelope-horn Qingfei Xiaoyan Wan for acute bronchitis with phlegm-heat obstructing the lung
CTR20213435Phase 3Active
- Sponsor
- Darentang
- Start
- Mar 2022
- Countries
- 1
01
Overview
A Phase 3 trial of Qingfei Xiaoyan Wan in acute bronchitis, sponsored by Darentang. Started Mar 2022; status: active.
02
Drugs
Qingfei Xiaoyan Wan
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20213435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213435.